EWG Elevate’s BioNTech BNTX Stock Holding History

EWG Elevate’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-112	Closed	-$16.8K	–	155
2022 Q4	$16.8K	Buy	+112	New	+$17.2K	0.01%	318

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

EWG Elevate's BNTX Position: Q1 2023 in Review

EWG Elevate sold out of BioNTech (BNTX) in Q1 2023, closing a stake of 112 shares — an estimated $16.8K sold.

EWG Elevate first reported a position in BNTX in Q4 2022 and held it in 1 quarter. The position peaked at $16.8K in Q4 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q1 2023.

EWG Elevate reported no remaining BioNTech position as of Q1 2023 after selling out during the quarter.
EWG Elevate sold 112 BioNTech shares in Q1 2023, an estimated $16.8K.
EWG Elevate first reported a position in BioNTech in Q4 2022 and held it in 1 quarter.
EWG Elevate's BioNTech position peaked at $16.8K in Q4 2022.
282 funds tracked by Wall St. Rank held BioNTech as of Q1 2023.

Based on EWG Elevate's 13F filing for Q1 2023, filed 13 Apr 2023.